COEXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RECEPTORIN HUMAN GASTRIC-CANCER CELL-LINES CORRELATES WITH THEIR INVASIVENESSAND TUMORIGENICITY
Ik. Park et al., COEXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RECEPTORIN HUMAN GASTRIC-CANCER CELL-LINES CORRELATES WITH THEIR INVASIVENESSAND TUMORIGENICITY, International journal of cancer, 71(5), 1997, pp. 867-873
The expression of urokinase-type plasminogen activator (u-PA), its rec
eptor (u-PAR) and metalloproteases activity were analyzed in 4 human g
astric-cancer cell lines (AGS, Hs746T, SNU-1, and SNU-5), in an attemp
t to relate these activities to their invasive potential acid tumorige
nicity on the modified chorioallantoic membranes (CAM) of chick embryo
s, Only I of the 4 cell lines tested, Hs746T, expressed both u-PA and
u-PAR as well as MMP-2, but not MMP-9. This cell line was both tumorig
enic and highly invasive (51.3 +/- 13.1%) on a modified CAM, Its invas
ive capacity was comparable with that of a highly malignant human epid
ermoid-carcinoma cell line (HEp3), which usually showed 40 to 50% inva
siveness, The 3 other cell lines all produced MMP-2 and MMP-9, but onl
y AGS showed moderate invasiveness (24.2 +/- 8.8%). While antibodies t
o u-PA were significantly effective in reducing CAM invasiveness of Hs
746T cells by approximately 40%, the invasiveness of the t-PA-expressi
ng ACS cell line was not affected by anti-t-PA antibodies, These resul
ts suggest that when one of the components of the u-PA/u-PAR system (t
he enzyme and/or the receptor) is not produced and u-PA/u-PAR-dependen
t cell-surface proteolytic activity is thereby diminished, the maligna
nt phenotype that can be determined by tumorigenicity and invasion of
connective tissue on a CAM is compromised. Production of both type-IV
collagenases (MMP-2 and MMP-9) cannot offset this deficiency. (C) 1997
Wiley-Liss, Inc.